Conquering COVID / Sinovac: An Unlikely Hero

by Peter Halesworth

Overview

For a world eagerly waiting to be freed from the suffocating COVID-19 pandemic, Sinovac is becoming a household name. The small Chinese company is planning to produce 1 billion doses of its vaccine, and inoculations have begun in some of the poorest and most populous nations on three continents. While a leader in China in vaccine development, Sinovac is largely unknown to much of the world. In "Conquering COVID," author Peter Halesworth uses his seven years of experience with the company to provide an in-depth look at its rough-and-tumble history, its turbulent present, and its breakthrough in developing a vaccine that promises to help end a global pandemic.

Product Details

ISBN-13:	9781666250770
Publisher:	Barnes & Noble Press
Publication date:	02/17/2021
Pages:	118
Product dimensions:	5.50(w) x 8.50(h) x 0.25(d)

About the Author

Peter Halesworth is the founder and portfolio manager of Heng Ren Partners, a Boston asset management firm investing in Chinese companies not researched by Wall Street banks. The firm has engaged several Chinese companies as an activist investor.

Mr. Halesworth started Heng Ren in 2013 after a career in inter- national investment banking, which included coverage of China.

He is the author of a 2016 whitepaper Chinese “Squeeze outs” in American Stock Markets and the Need to Protect U.S. Investors.

He was a reporter for The Patriot Ledger in Quincy, Massachusetts, from 1988 until 1992, when he joined the Associated Press-Dow Jones News Service. He moved to Jakarta, Indonesia, in 1994 to open an office for the company, and served two years as bureau chief.

Mr. Halesworth received his bachelor’s degree from Vassar College with a major in history and was awarded a Maguire Fellowship in Indonesia. He lives outside Boston with his four children.